Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Meditation may lower blood pressure risk in menopause

NCT ID NCT07314827

Prevention Sponsor: University of Miami Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether a 12-week Transcendental Meditation (TM) program can improve stress, mood, and blood pressure in post-menopausal women at risk for hypertension. Sixty women aged 50-80 with mildly elevated blood pressure and stress will be randomly assigned to TM or a Women's Health Education group. The goal is to see if TM is a feasible and promising non-drug approach to prevent hypertension.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcendental Meditation (TM)
What this could lead to
If successful, this could provide a non-drug method to help prevent hypertension in post-menopausal women.
What could go wrong
This is a small feasibility study (60 participants) that hasn't started yet. It's designed to test if the approach works and is practical, not to prove effectiveness. Results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ≥130 systolic blood pressure (SBP) ≤160 and/or 84 ≥ diastolic blood pressure (DBP) ≤100. 2. Perceived stress scale (PSS-4) \> 5 3. Able to give informed consent. 4. Understand study procedures and comply with them for the length of the study. 5. Ages between 50 and 80 years. 6. Post-menopausal ≥ 1 year since last menstruation 7. Reads and speaks English 8. UHealth patients 9. Working at least part-time Exclusion Criteria: 1. Currently in a meditation program. 2. Meditates more than once per week 3. Recent stroke or cerebral neurologic impairment. 4. Current uses of mood stabilizers or antipsychotics. 5. Has been diagnosed with bipolar disorder, schizophrenia, or substance use disorder. 6. Inability to give written informed consent in English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health education are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Health Education hypertensive disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health education Meditation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Miami

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.